Pioneering diagnostics
E.g., 11/02/2016
E.g., 11/02/2016

BioFire’s FilmArray® Meningitis/Encephalitis Panel gets CE marked

FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform

26 January, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today announced the availability of BioFire Diagnostics’ FilmArray® Meningitis/Encephalitis (ME) Panel in the countries which recognize CE marking. The ME Panel provides unique and...

bioMérieux – Fourth-Quarter 2015 Business Review

20 January, 2016

  • Robust sales dynamic, driving 7.1% organic growth for the year:
    • €1,965 million in sales
    • Up 15.7% as reported
    ...

BioFire Submits Special 510(k) Application to the FDA for the use of FilmArray® Torch, the New High Throughput FilmArray® System with FilmArray® Respiratory Panel

FilmArray® Torch delivers high throughput, radically smaller footprint

12 January, 2016

 bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, LLC, its molecular biology affiliate, has submitted the FilmArray® Torch to the U.S. Food and Drug Administration (FDA) for special510(...

bioMérieux acquires Applied Maths and enhances its bioinformatics capabilities with cutting-edge expertise and solutions for the smart use of complex biological data

05 January, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and...

bioMérieux and Illumina announce the launch of bioMérieux EpiSeq™, a revolutionary Next-Generation Sequencing service for epidemiological monitoring of bacterial infections

14 December, 2015

bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina (Nasdaq: ILMN), a world...

bioMérieux introduces GENE-UP®, a new molecular diagnostic solution for food pathogen detection  jointly developed with BioFire

New generation PCR system benefits from the combined expertise of bioMérieux, world leader in microbiological food safety control and of BioFire, reputed for its know-how in molecular biology

04 November, 2015

bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of GENE-UP®, its new PCR-based molecular diagnostic system for the detection of microorganisms (bacteria and viruses). This platform enables the microbiological control of food, raw...

bioMérieux – Business review for the nine months ended September 30, 2015

22 October, 2015

  •  Robust growth in nine-month sales:
    •  Sales reached €1,412 million...

BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray® Meningitis/Encephalitis panel continuing its extremely favorable business momentum

FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform

09 October, 2015

Marcy l’Étoile, France – October 9, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced, as issued in a press release by the U.S. Food and Drug Administration (FDA) yesterday, that BioFire Diagnostics, its molecular biology...

BioFire Defense, a bioMérieux company, receives Emergency Use Assessment and Listing for FilmArray® Ebola Test by the World Health Organization

24 September, 2015

Marcy l’Etoile (France) – September 24, 2015 – BioFire Defense, LLC of Salt Lake City, UT announces that its FilmArray® Ebola test (BioThreat-E test1) has received Emergency Use Assessment and...

bioMérieux – First-Half 2015 Results

31 August, 2015

  • Strong growth in business
    • €933 million in sales
    • ...